Literature DB >> 30359703

A 13-week subchronic toxicity study of 2-ethylbutanal in F344 rats.

Kohei Matsushita1, Takeshi Toyoda2, Tomomi Morikawa1, Miwa Takahashi1, Kaoru Inoue1, Kumiko Ogawa1.   

Abstract

2-Ethylbutanal (2-EB) has been used as a flavoring agent. Here, we performed a 13-week subchronic toxicity study of 2-EB in F344 rats. 2-EB was given orally by gavage, using doses of 0, 50, 200 or 800 mg/kg BW/day. Reduced body weight gain was noted in both sexes at 800 mg/kg BW. Hematologic assessment showed a decrease in platelet counts in males at 200 mg/kg BW and both sexes at 800 mg/kg BW. Serum biochemistry demonstrated increases in inorganic phosphorus in both sexes at 200 and 800 mg/kg BW, increases in glucose in females at 200 and 800 mg/kg BW and increases in urea nitrogen in both sexes at 800 mg/kg BW. Regarding organ weights, increases in absolute and relative weights of the liver and kidney with toxicological significance were detected in both sexes at 200 and 800 mg/kg BW. Hepatocellular hypertrophy with eosinophilic granular cytoplasmic changes in the liver were observed in males at 200 mg/kg BW and in both sexes at 800 mg/kg BW. Necrosis/regeneration of proximal tubules in the kidney was detected in females at 800 mg/kg BW. Based on these results, the no-observed-adverse-effect level (NOAEL) of 2-EB was evaluated to be 50 mg/kg BW/day for both sexes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Ethylbutanal; F344 rats; Flavoring agent; Hepatocellular hypertrophy; Renal tubular necrosis; Subchronic toxicity

Mesh:

Substances:

Year:  2018        PMID: 30359703     DOI: 10.1016/j.yrtph.2018.10.012

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  1 in total

1.  A 13-week subchronic toxicity study of hexyl acetate in SD rats.

Authors:  Takeshi Toyoda; Young-Man Cho; Kohei Matsushita; Shigehiro Tachibana; Mika Senuma; Jun-Ichi Akagi; Kumiko Ogawa
Journal:  J Toxicol Pathol       Date:  2019-03-29       Impact factor: 1.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.